285 related articles for article (PubMed ID: 37150655)
1. An update on selected cutaneous (myo) fibroblastic mesenchymal tumors.
Georgantzoglou N; Linos K
Semin Diagn Pathol; 2023 Jul; 40(4):295-305. PubMed ID: 37150655
[TBL] [Abstract][Full Text] [Related]
2. PRAME immunohistochemistry in soft tissue tumors and mimics: a study of 350 cases highlighting its imperfect specificity but potentially useful diagnostic applications.
Cammareri C; Beltzung F; Michal M; Vanhersecke L; Coindre JM; Velasco V; Le Loarer F; Vergier B; Perret R
Virchows Arch; 2023 Aug; 483(2):145-156. PubMed ID: 37477762
[TBL] [Abstract][Full Text] [Related]
3. Fibroblastic and Myofibroblastic Soft-Tissue Tumors: Imaging Spectrum and Radiologic-Pathologic Correlation.
Haseli S; Mansoori B; Christensen D; Abadi A; Pooyan A; Shomal Zadeh F; Mau B; Khalili N; Murphey M; Chalian M
Radiographics; 2023 Aug; 43(8):e230005. PubMed ID: 37440448
[TBL] [Abstract][Full Text] [Related]
4. Soft Tissue Special Issue: Fibroblastic and Myofibroblastic Neoplasms of the Head and Neck.
Baranov E; Hornick JL
Head Neck Pathol; 2020 Mar; 14(1):43-58. PubMed ID: 31950474
[TBL] [Abstract][Full Text] [Related]
5. Apolipoprotein D in CD34-positive and CD34-negative cutaneous neoplasms: a useful marker in differentiating superficial acral fibromyxoma from dermatofibrosarcoma protuberans.
Lisovsky M; Hoang MP; Dresser KA; Kapur P; Bhawan J; Mahalingam M
Mod Pathol; 2008 Jan; 21(1):31-8. PubMed ID: 17885669
[TBL] [Abstract][Full Text] [Related]
6. Recent advances in the diagnosis, classification and molecular pathogenesis of cutaneous mesenchymal neoplasms.
Papke DJ; Hornick JL
Histopathology; 2022 Jan; 80(1):216-232. PubMed ID: 34958499
[TBL] [Abstract][Full Text] [Related]
7. Practical approach to diagnosis of bland-looking spindle cell lesions of the breast.
Magro G; Salvatorelli L; Puzzo L; Piombino E; Bartoloni G; Broggi G; Vecchio GM
Pathologica; 2019 Dec; 111(4):344-360. PubMed ID: 31965112
[TBL] [Abstract][Full Text] [Related]
8. From Morphea to Dermatofibrosarcoma Protuberans.
Crnarić I; Šitum M; Delaš Aždajić M; Vučić M; Buljan M
Acta Dermatovenerol Croat; 2022 Sep; 30(2):113-115. PubMed ID: 36254545
[TBL] [Abstract][Full Text] [Related]
9. [Fibrohistiocytic tumors of the skin: a heterogeneous group of superficially located mesenchymal neoplasms].
Mentzel T
Pathologe; 2015 Feb; 36(1):79-88. PubMed ID: 25589356
[TBL] [Abstract][Full Text] [Related]
10. Expression of bcl-2 oncoprotein in benign and malignant spindle cell tumors of soft tissue, skin, serosal surfaces, and gastrointestinal tract.
Suster S; Fisher C; Moran CA
Am J Surg Pathol; 1998 Jul; 22(7):863-72. PubMed ID: 9669348
[TBL] [Abstract][Full Text] [Related]
11. Current Update on the Molecular Biology of Cutaneous Sarcoma: Dermatofibrosarcoma Protuberans.
Iwasaki T; Yamamoto H; Oda Y
Curr Treat Options Oncol; 2019 Mar; 20(4):29. PubMed ID: 30874910
[TBL] [Abstract][Full Text] [Related]
12. Differential expression of smooth muscle myosin, smooth muscle actin, h-caldesmon, and calponin in the diagnosis of myofibroblastic and smooth muscle lesions of skin and soft tissue.
Perez-Montiel MD; Plaza JA; Dominguez-Malagon H; Suster S
Am J Dermatopathol; 2006 Apr; 28(2):105-11. PubMed ID: 16625070
[TBL] [Abstract][Full Text] [Related]
13. Cutaneous soft tissue tumors: how do we make sense of fibrous and "fibrohistiocytic" tumors with confusing names and similar appearances?
Hornick JL
Mod Pathol; 2020 Jan; 33(Suppl 1):56-65. PubMed ID: 31653978
[TBL] [Abstract][Full Text] [Related]
14. Immunohistochemical characterization of dermatofibrosarcoma protuberans with practical applications for diagnosis and treatment.
Haycox CL; Odland PB; Olbricht SM; Piepkorn M
J Am Acad Dermatol; 1997 Sep; 37(3 Pt 1):438-44. PubMed ID: 9308560
[TBL] [Abstract][Full Text] [Related]
15. Sclerosing dermatofibrosarcoma protuberans (DFSP): an unusual variant with focus on the histopathologic differential diagnosis.
Sabater-Marco V; Pérez-Vallés A; Berzal-Cantalejo F; Rodriguez-Serna M; Martinez-Diaz F; Martorell-Cebollada M
Int J Dermatol; 2006 Jan; 45(1):59-62. PubMed ID: 16426380
[TBL] [Abstract][Full Text] [Related]
16. CD34-reactive tumors of the skin. An updated review of an ever-growing list of lesions.
Tardío JC
J Cutan Pathol; 2008 Dec; 35(12):1079-92. PubMed ID: 18976402
[TBL] [Abstract][Full Text] [Related]
17. Fibroblastic and myofibroblastic tumors of the head and neck: comprehensive imaging-based review with pathologic correlation.
Hourani R; Taslakian B; Shabb NS; Nassar L; Hourani MH; Moukarbel R; Sabri A; Rizk T
Eur J Radiol; 2015 Feb; 84(2):250-60. PubMed ID: 25467227
[TBL] [Abstract][Full Text] [Related]
18. Myxoid dermatofibrosarcoma protuberans: clinicopathologic, immunohistochemical, and molecular analysis of eight cases.
Mentzel T; Schärer L; Kazakov DV; Michal M
Am J Dermatopathol; 2007 Oct; 29(5):443-8. PubMed ID: 17890911
[TBL] [Abstract][Full Text] [Related]
19. TGFBR3 and MGEA5 rearrangements are much more common in "hybrid" hemosiderotic fibrolipomatous tumor-myxoinflammatory fibroblastic sarcomas than in classical myxoinflammatory fibroblastic sarcomas: a morphological and fluorescence in situ hybridization study.
Zreik RT; Carter JM; Sukov WR; Ahrens WA; Fritchie KJ; Montgomery EA; Weiss SW; Folpe AL
Hum Pathol; 2016 Jul; 53():14-24. PubMed ID: 26980036
[TBL] [Abstract][Full Text] [Related]
20. Dermatofibrosarcoma protuberans: pathology, genetics, and potential therapeutic strategies.
Thway K; Noujaim J; Jones RL; Fisher C
Ann Diagn Pathol; 2016 Dec; 25():64-71. PubMed ID: 27806849
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
